Overview
Qingyun Kang practices in Changsha, China. Kang is rated as an Advanced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Drug Induced Dyskinesia, and Myoclonic Epilepsy.
Their clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Anti-NMDA Receptor Encephalitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Anti-NMDA Receptor Encephalitis
- Experienced
- CACH SyndromeKang isExperienced. Learn about CACH Syndrome.
- Drug Induced DyskinesiaKang isExperienced. Learn about Drug Induced Dyskinesia.
- EncephalitisKang isExperienced. Learn about Encephalitis.
- EpilepsyKang isExperienced. Learn about Epilepsy.
- Epilepsy in ChildrenKang isExperienced. Learn about Epilepsy in Children.
- LeukocytosisKang isExperienced. Learn about Leukocytosis.